Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112


Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Cancer. 2015 Oct 1;121(19):3543-50. doi: 10.1002/cncr.29516. Epub 2015 Jun 10.


Diurnal cortisol and survival in epithelial ovarian cancer.

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20.


Vaccine immunotherapy for prostate cancer: from mice to men.

Lubaroff DM, Vaena D, Brown JA, Zehr P, Griffith KC, Brown E, Eastman J, Nepple K, Kattula A, Williams RD.

Immunol Res. 2014 Aug;59(1-3):229-35. doi: 10.1007/s12026-014-8531-2.


Prostate cancer vaccines in combination with additional treatment modalities.

Uhlman MA, Bing MT, Lubaroff DM.

Immunol Res. 2014 Aug;59(1-3):236-42. doi: 10.1007/s12026-014-8532-1. Review.


The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

PLoS One. 2013 Jun 28;8(6):e67904. doi: 10.1371/journal.pone.0067904. Print 2013.


Proposed mechanisms of action for prostate cancer vaccines.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

Nat Rev Urol. 2013 Mar;10(3):149-60. doi: 10.1038/nrurol.2013.8. Epub 2013 Feb 12. Review.


Prostate cancer vaccines in clinical trials.

Lubaroff DM.

Expert Rev Vaccines. 2012 Jul;11(7):857-68. doi: 10.1586/erv.12.54. Review.


Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA 3rd, Ganjei-Azar P, Mendez L, Markon K, Lubaroff DM, Thaker PH, Slavich GM, Sood AK, Lutgendorf SK.

Brain Behav Immun. 2013 Mar;30 Suppl:S126-34. doi: 10.1016/j.bbi.2012.07.022. Epub 2012 Aug 5.


Social influences on clinical outcomes of patients with ovarian cancer.

Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA 3rd, Ganjei-Azar P, Thaker PH, Mendez L, Lubaroff DM, Slavich GM, Cole SW, Sood AK.

J Clin Oncol. 2012 Aug 10;30(23):2885-90. doi: 10.1200/JCO.2011.39.4411. Epub 2012 Jul 16.


Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.

Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Penedo F, Lubaroff DM, Sood AK, Lutgendorf SK.

Brain Behav Immun. 2012 Oct;26(7):1037-44. doi: 10.1016/j.bbi.2012.04.003. Epub 2012 Apr 21.


Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Lemke CD, Graham JB, Geary SM, Zamba G, Lubaroff DM, Salem AK.

Mol Pharm. 2011 Oct 3;8(5):1652-61. doi: 10.1021/mp100464y. Epub 2011 Aug 9.


Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

Cancer Immunol Immunother. 2011 Sep;60(9):1309-17. doi: 10.1007/s00262-011-1038-y. Epub 2011 May 28.


Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.

Lemke CD, Graham JB, Lubaroff DM, Salem AK.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):118-21. doi: 10.1038/pcan.2010.57. Epub 2011 Jan 25.


Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing.

Lamkin DM, Lutgendorf SK, Lubaroff D, Sood AK, Beltz TG, Johnson AK.

Brain Behav Immun. 2011 Mar;25(3):555-64. doi: 10.1016/j.bbi.2010.12.010. Epub 2010 Dec 21.


Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.

Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW.

Brain Behav Immun. 2011 Feb;25(2):250-5. doi: 10.1016/j.bbi.2010.10.012. Epub 2010 Oct 16.


Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.

Lutgendorf SK, Mullen-Houser E, Russell D, Degeest K, Jacobson G, Hart L, Bender D, Anderson B, Buekers TE, Goodheart MJ, Antoni MH, Sood AK, Lubaroff DM.

Brain Behav Immun. 2010 Nov;24(8):1231-40. doi: 10.1016/j.bbi.2010.06.014. Epub 2010 Jun 30.


Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.

Weinrib AZ, Sephton SE, Degeest K, Penedo F, Bender D, Zimmerman B, Kirschbaum C, Sood AK, Lubaroff DM, Lutgendorf SK.

Cancer. 2010 Sep 15;116(18):4410-9. doi: 10.1002/cncr.25299.


Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results.

Lubaroff DM, Konety BR, Link B, Gerstbrein J, Madsen T, Shannon M, Howard J, Paisley J, Boeglin D, Ratliff TL, Williams RD.

Clin Cancer Res. 2009 Dec 1;15(23):7375-80. doi: 10.1158/1078-0432.CCR-09-1910. Epub 2009 Nov 17.


CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

Lubaroff DM, Karan D.

Adv Drug Deliv Rev. 2009 Mar 28;61(3):268-74. doi: 10.1016/j.addr.2008.12.005. Epub 2009 Jan 7. Review.


Glucose as a prognostic factor in ovarian carcinoma.

Lamkin DM, Spitz DR, Shahzad MM, Zimmerman B, Lenihan DJ, Degeest K, Lubaroff DM, Shinn EH, Sood AK, Lutgendorf SK.

Cancer. 2009 Mar 1;115(5):1021-7. doi: 10.1002/cncr.24126.


Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JM, Penedo F, DeGeest K, Langley RR, Lucci JA 3rd, Cole SW, Lubaroff DM, Sood AK.

Clin Cancer Res. 2008 Nov 1;14(21):6839-46. doi: 10.1158/1078-0432.CCR-08-0230.


Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Costanzo ES, Henderson PJ, Sephton SE, Rohleder N, Lucci JA 3rd, Cole S, Sood AK, Lubaroff DM.

J Clin Oncol. 2008 Oct 10;26(29):4820-7. doi: 10.1200/JCO.2007.14.1978. Epub 2008 Sep 8.


Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.

Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci J 3rd, Goodheart M, Lubaroff D, Farley DM, Sood AK, Cole SW.

Brain Behav Immun. 2009 Feb;23(2):176-83. doi: 10.1016/j.bbi.2008.04.155. Epub 2008 Jun 11.


Prostate cancer: genes, environment, immunity and the use of immunotherapy.

Karan D, Thrasher JB, Lubaroff D.

Prostate Cancer Prostatic Dis. 2008;11(3):230-6. doi: 10.1038/pcan.2008.3. Epub 2008 Feb 19. Review.


Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.

Lutgendorf SK, Lamkin DM, DeGeest K, Anderson B, Dao M, McGinn S, Zimmerman B, Maiseri H, Sood AK, Lubaroff DM.

Brain Behav Immun. 2008 Aug;22(6):890-900. doi: 10.1016/j.bbi.2007.12.012. Epub 2008 Feb 13.


Positive psychosocial factors and NKT cells in ovarian cancer patients.

Lamkin DM, Lutgendorf SK, McGinn S, Dao M, Maiseri H, DeGeest K, Sood AK, Lubaroff DM.

Brain Behav Immun. 2008 Jan;22(1):65-73. Epub 2007 Jul 23.


Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer.

Lubaroff DM, Karan D, Andrews MP, Acosta A, Abouassaly C, Sharma M, Krieg AM.

Vaccine. 2006 Aug 28;24(35-36):6155-62. Epub 2006 May 3.


Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer.

Lubaroff DM, Konety B, Link BK, Ratliff TL, Madsen T, Shannon M, Ecklund D, Williams RD.

Hum Gene Ther. 2006 Feb;17(2):220-9. No abstract available.


Social support, psychological distress, and natural killer cell activity in ovarian cancer.

Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM.

J Clin Oncol. 2005 Oct 1;23(28):7105-13.


Psychosocial factors and interleukin-6 among women with advanced ovarian cancer.

Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM.

Cancer. 2005 Jul 15;104(2):305-13.


Dual roles of E-cadherin in prostate cancer invasion.

Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor RE, Amir S, Lubaroff DM, Heidger PM Jr, Hendrix MJ.

J Cell Biochem. 2004 Mar 1;91(4):649-61.


Effects of acute stress, relaxation, and a neurogenic inflammatory stimulus on interleukin-6 in humans.

Lutgendorf SK, Logan H, Costanzo E, Lubaroff D.

Brain Behav Immun. 2004 Jan;18(1):55-64.


Effects of stress and relaxation on capsaicin-induced pain.

Logan H, Lutgendorf S, Rainville P, Sheffield D, Iverson K, Lubaroff D.

J Pain. 2001 Jun;2(3):160-70.


Molecular pathology of non-invasive urothelial carcinomas (part I).

Helpap B, Schmitz-Dräger BJ, Hamilton PW, Muzzonigro G, Galosi AB, Kurth KH, Lubaroff D, Waters DJ, Droller MJ.

Virchows Arch. 2003 Apr;442(4):309-16. Epub 2003 Feb 11. Review.


A pilot study of immune and mood outcomes of a community-based intervention for dementia caregivers: the PLST intervention.

Garand L, Buckwalter KC, Lubaroff D, Tripp-Reimer T, Frantz RA, Ansley TN.

Arch Psychiatr Nurs. 2002 Aug;16(4):156-67.


Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry.

Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM, Hendrix MJ.

Prostate. 2002 Feb 15;50(3):189-201.


Pain and immunologic response to root canal treatment and subsequent health outcomes.

Logan HL, Lutgendorf S, Kirchner HL, Rivera EM, Lubaroff D.

Psychosom Med. 2001 May-Jun;63(3):453-62.


Effects of housing relocation on immunocompetence and psychosocial functioning in older adults.

Lutgendorf SK, Reimer TT, Harvey JH, Marks G, Hong SY, Hillis SL, Lubaroff DM.

J Gerontol A Biol Sci Med Sci. 2001 Feb;56(2):M97-105.


Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix.

Siemens DR, Elzey BD, Lubaroff DM, Bohlken C, Jensen RJ, Swanson AK, Ratliff TL.

J Immunol. 2001 Jan 15;166(2):731-5.


Effects of relaxation and stress on the capsaicin-induced local inflammatory response.

Lutgendorf S, Logan H, Kirchner HL, Rothrock N, Svengalis S, Iverson K, Lubaroff D.

Psychosom Med. 2000 Jul-Aug;62(4):524-34.


Macropinocytosis as a mechanism of entry into primary human urethral epithelial cells by Neisseria gonorrhoeae.

Zenni MK, Giardina PC, Harvey HA, Shao J, Ketterer MR, Lubaroff DM, Williams RD, Apicella MA.

Infect Immun. 2000 Mar;68(3):1696-9.


gamma-linolenic acid (GLA)-mediated cytotoxicity in human prostate cancer cells.

Robbins M, Ali K, McCaw R, Olsen J, Vartak S, Lubaroff D.

Adv Exp Med Biol. 1999;469:499-504. No abstract available.


Sense of coherence moderates the relationship between life stress and natural killer cell activity in healthy older adults.

Lutgendorf SK, Vitaliano PP, Tripp-Reimer T, Harvey JH, Lubaroff DM.

Psychol Aging. 1999 Dec;14(4):552-63.


Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.

Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM.

J Gerontol A Biol Sci Med Sci. 1999 Sep;54(9):M434-9.


A novel immunological model for the study of prostate cancer.

Sharma N, Luo J, Kirschmann DA, O'Malley Y, Robbins ME, Akporiaye ET, Lubaroff DM, Heidger PM, Hendrix MJ.

Cancer Res. 1999 May 15;59(10):2271-6.


Neisseria gonorrhoeae induces focal polymerization of actin in primary human urethral epithelium.

Giardina PC, Williams R, Lubaroff D, Apicella MA.

Infect Immun. 1998 Jul;66(7):3416-9.


Alterations in constituent urinary proteins in response to bladder outlet obstruction in rats.

Burns JA, Kreder KJ, Lubaroff DM, See WA.

J Urol. 1998 May;159(5):1747-51.


Supplemental Content

Loading ...
Support Center